Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients

Hormozgan University of Medical Sciences74 enrolled

Overview

This is double blind randomized controlled trial on the statins effects on serum IgG, IgA and IgM level in chronic hemodialysis patients in Bandarabbas

This study is a randomized controlled trial of statins effect on serum IgG, IgA and IgM level on chronic hemodialysis patients in Bandarabbas. The study is carried out in Hormozgan, Iran. Seventy four patient were randomized either to receive atorvastatin in addition of usual treatment or not. The primary outcomes were serum IgG,IgA and IgM level. The secondary outcome was drug side effects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Chronic Kidney Disease

Interventions

LipitorDRUG

Atorvastatin 20mg daily for 6 months

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All chronic hemodialysis patients attending Shahid Mohammadi hospital during the study period * Accepting to participate in the study Exclusion Criteria: * Refusing to participate in the study

Locations (1)

Shahid Mohammadi hospital

Bandar Abbas, Hormozgan, Iran

Outcomes

Primary Outcomes

Serum IgG, IgA and IgM level

Time frame: 6 months

Secondary Outcomes

Drug side effects

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.